PRELUDE CAPITAL MANAGEMENT, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2020$66,000
+2100.0%
5,029
+1783.5%
0.00%
Q2 2020$3,000
-62.5%
267
-5.3%
0.00%
-100.0%
Q4 2018$8,0000.0%282
+72.0%
0.00%
Q3 2018$8,000
-50.0%
164
-60.7%
0.00%
-100.0%
Q2 2018$16,000
-94.9%
417
-96.6%
0.00%
-96.7%
Q2 2017$312,000
-61.4%
12,092
-71.3%
0.03%
-61.0%
Q1 2017$809,000
+52.1%
42,110
+32.0%
0.08%
+20.3%
Q4 2016$532,000
+250.0%
31,899
+330.6%
0.06%
+300.0%
Q3 2016$152,000
+7.8%
7,408
+61.0%
0.02%
-20.0%
Q2 2016$141,000
+642.1%
4,600
+736.4%
0.02%
+566.7%
Q2 2015$19,000
-51.3%
550
-50.0%
0.00%
-40.0%
Q1 2015$39,000
-91.9%
1,100
-91.2%
0.01%
-92.6%
Q3 2014$483,000
-39.2%
12,521
-38.7%
0.07%
-35.2%
Q2 2014$795,000
-7.3%
20,436
-18.6%
0.10%
-8.7%
Q1 2014$858,000
+90.2%
25,115
+16.7%
0.12%
+55.4%
Q4 2013$451,000
+101.3%
21,525
+125.1%
0.07%
+105.6%
Q3 2013$224,0009,5620.04%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders